TrianglePUBLICATIONS · 28228106
Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Hematol Oncol
- Publication date
- 2017 Feb 22
- First author
- Verstovsek S
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Verstovsek S
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Gotlib J
- type
- Author
- name
- Gupta V
- type
- Author
- name
- DiPersio JF
- type
- Author
- name
- Catalano JV
- type
- Author
- name
- Deininger MW
- type
- Author
- name
- Miller CB
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Winton EF
- type
- Author
- name
- Harvey JH Jr
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Verstovsek S
- type
- Author
- name
- Mesa RA
- type
- Author
- name
- Gotlib J
- type
- Author
- name
- Gupta V
- type
- Author
- name
- DiPersio JF
- type
- Author
- name
- Catalano JV
- type
- Author
- name
- Deininger MW
- type
- Author
- name
- Miller CB
- type
- Author
- name
- Silver RT
- type
- Author
- name
- Talpaz M
- type
- Author
- name
- Winton EF
- type
- Author
- name
- Harvey JH Jr
- type
- Author
- bibliography ids
- nci-bib-3ebda05e5f59294c4f6abe16
- book metadata
- content sha256
- e03fb9b5ef69a4fb4c7f19bc118ae0baa174b435b18f3260e845b8a527c3cc7c
- document type
- citation
- dois
- 10.1186/s13045-017-0417-z
- electronic publication date
- display
- 2017 Feb 22
- precision
- day
- year
- 2017
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:28228106
- immutable id
- pubmed:28228106@e03fb9b5ef69a4fb4c7f19bc118ae0baa174b435b18f3260e845b8a527c3cc7c
- journal
- abbreviation
- J Hematol Oncol
- issn electronic
- 1756-8722
- issn print
- Source null
- issue
- 1
- name
- Journal of hematology & oncology
- nlm unique id
- 101468937
- pages
- 55
- volume
- 10
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 28228106
- provenance
- batch id
- 7a1288ac8bb5f9826304
- provider
- NCBI PubMed ESummary
- record sha256
- 42e35ff143c21613c2b7b2e3e052037b2a54bcfd12bf7eceb58eb768c855c9c7
- response sha256
- 0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
- retrieved at
- 2026-09-09T23:47:23.138359+00:00
- publication date
- display
- 2017 Feb 22
- precision
- day
- year
- 2017
- publication types
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term treatment with ruxolitinib for patients with myelofibrosis: 5-year update from the randomized, double-blind, placebo-controlled, phase 3 COMFORT-I trial.
Preserved source evidence · Not medical advice